Javidi-Sharifi Nathalie - Dana-Farber Cancer Institute, Harvard Medical School

基本信息

浏览量：13

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 28 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluating Zanubrutinib for the Treatment of Adults with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nathalie Javidi-Sharifi,Jennifer R Brown

Expert review of hematologypp.1-10, (2024)

引用0浏览0WOS引用

Supplemental Figures from FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

Elie Traer,Jacqueline Martinez,Nathalie Javidi-Sharifi, Anupriya Agarwal,Jennifer Dunlap,Isabel English,Tibor Kovacsovics, Jeffrey W. Tyner,Melissa H. Wong,Brian J. Druker

openalex（2023）

引用0浏览0引用

Supplemental Figure Legends from FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

Elie Traer,Jacqueline Martinez,Nathalie Javidi-Sharifi, Anupriya Agarwal,Jennifer Dunlap,Isabel English,Tibor Kovacsovics, Jeffrey W. Tyner,Melissa H. Wong,Brian J. Druker

openalex（2023）

引用0浏览0引用

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL) or Acute Myeloid Leukemia (AML)

Matthew S. Davids,Yesid Alvarado Valero,Catherine Diefenbach,Daniel Egan,Shira Dinner,Monzr M. Al Malki,Kebede H. Begna,Avyakta Kallam,Sameem Abedin,Rachel J. Cook,Nathalie Javidi-Sharifi, Edward A. Dominguez, Miao Lü,Richard Ghalie,Alexey V. Danilov

Bloodno. Supplement 1 (2023): 4286-4286

引用0浏览0引用

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL) or Acute Myeloid Leukemia (AML)

Matthew S. Davids,Yesid Alvarado Valero,Catherine Diefenbach,Daniel N. Egan,Shira N. Dinner,Monzr M. Al Malki,Kebede Begna,Avyakta Kallam,Sameem Abedin,Rachel Cook,Nathalie Javidi-Sharifi,Edward Dominguez, Lu Miao,Richard G. Ghalie,Alexey Danilov

Bloodno. Supplement 1 (2023): 4286-4286

引用0浏览0引用

Supplementary Tables S1-S2, Figures S1-S9, and Methods from Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance

Nathalie Javidi-Sharifi,Elie Traer,Jacqueline Martinez,Anu Gupta, Takehiro Taguchi,Jennifer Dunlap,Michael C. Heinrich,Christopher L. Corless,Brian P. Rubin,Brian J. Druker,Jeffrey W. Tyner

crossref（2023）

引用0浏览0引用

Future Directions in Chronic Phase CML Treatment

Nathalie Javidi-Sharifi,Gabriela Hobbs

Current Hematologic Malignancy Reports（2021）

引用10浏览0引用

FGF2-FGFR1 Signaling Regulates Release of Leukemia-Protective Exosomes from Bone Marrow Stromal Cells

Nathalie Javidi-Sharifi,Jacqueline Martinez,Isabel English,Sunil K Joshi,Renata Scopim-Ribeiro,Shelton K Viola,David K Edwards,Anupriya Agarwal,Claudia Lopez,Danielle Jorgens,Jeffrey W Tyner,Brian J Druker,Elie Traer

eLife（2019）

引用56浏览0WOS引用

Erratum: Correction: FGF2-FGFR1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells (eLife (2019) 8 PII: e47174)

Nathalie Javidi-Sharifi,Jacqueline Martinez,Isabel English,Sunil K. Joshi,Renata Scopim-Ribeiro,Shelton K. Viola,David K. Edwards,Anupriya Agarwal,Claudia S. López,Danielle M. Jorgens,Jeffrey W. Tyner,Brian J. Druker,Elie Traer

eLife (2019)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn